13 Analysts Assess Teladoc Health: What You Need To Know
Portfolio Pulse from Benzinga Insights
13 analysts have recently updated their ratings and price targets for Teladoc Health (NYSE:TDOC), showing a mix of bullish and bearish sentiments. The average 12-month price target was adjusted to $21.15, marking an 18.37% decrease. The adjustments reflect changing market dynamics and Teladoc Health's performance, including a positive revenue trend with a growth rate of 3.58% as of December 31, 2023, but lagging behind industry peers. Despite a strong net margin and ROA, the company's debt management poses a challenge with a higher than average debt-to-equity ratio.
April 26, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Analysts have mixed opinions on Teladoc Health, with recent adjustments reflecting a decrease in the average price target to $21.15, indicating a negative sentiment shift. The company shows positive revenue growth and strong profitability metrics but faces challenges in debt management.
The decrease in the average price target by analysts suggests a bearish outlook for Teladoc Health in the short term, influenced by the negative sentiment shift and concerns over debt management despite positive revenue growth and profitability metrics.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100